Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_assertion type Assertion NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_head.
- NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_assertion description "[Until recently, liver transplantation (Ltx) was the only available treatment for hereditary transthyretin (TTR) amyloidosis; today, however, several pharmacotherapies are tested.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_provenance.
- NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_assertion evidence source_evidence_literature NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_provenance.
- NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_assertion SIO_000772 26308415 NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_provenance.
- NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_assertion wasDerivedFrom befree-2016 NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_provenance.
- NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_assertion wasGeneratedBy ECO_0000203 NP1293223.RAeh-zlujwV7EEZThQ4OhLcXddgMBAJo3q65cnpL496xI130_provenance.